每天三分钟公告很轻松 | ST中迪停牌核查已完成 18日起复牌
Shang Hai Zheng Quan Bao·2025-11-17 15:50

Core Points - ST Zhongdi has completed its suspension review and will resume trading on November 18, 2025 [1] - Ningde Times has preliminarily set the share transfer price at 376.12 yuan per share [8] - Shengyi Electronics plans to raise no more than 2.6 billion yuan for the construction of an AI computing HDI production base and other projects [1] - Dahua Technology intends to spin off its subsidiary Huairui Technology for an independent listing on the Hong Kong Stock Exchange [2] - Aystar Chemical plans to acquire 100% equity of Tianyi Chemical for a major asset restructuring [3] - Zhu Mian Group intends to transfer 100% equity of Gree Real Estate for 5.518 billion yuan [3] - Daimeis plans to establish a wholly-owned subsidiary for robotics business with an investment of 100 million yuan [10] - Lianang Microelectronics plans to invest 2.262 billion yuan in a project to produce 1.8 million pieces of 12-inch heavily doped substrate wafers [11] Focus One - Shengyi Electronics plans to issue A-shares to raise no more than 2.6 billion yuan, which will be used for the construction of an AI computing HDI production base, smart manufacturing high-layer circuit boards, and to supplement working capital and repay bank loans [1] Focus Two - Dahua Technology plans to spin off its subsidiary Huairui Technology for an independent listing, which will help enhance Huairui's capital strength and broaden financing channels [2] Major Transactions - Aystar Chemical intends to acquire 100% equity of Tianyi Chemical through a combination of share issuance and cash payment, with the transaction expected to constitute a major asset restructuring [3] - Zhu Mian Group plans to transfer its 100% equity of Gree Real Estate for a confirmed price of 5.518 billion yuan, marking a significant asset restructuring [3] Other Significant Events - Huaxia Happiness has received a court decision appointing a temporary administrator for its pre-restructuring period [4] - Mengke Pharmaceuticals has decided to terminate its plan to issue shares due to disagreements among major shareholders [5] - Hubei Broadcasting has received a notification regarding the transfer of equity in Chutian Network, which will not change the controlling shareholder [6] - Da'an Gene is undergoing a significant share transfer that may result in a change of indirect control [7]